Cargando…
The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020
Cancer is one of the important health problems in Iran, which is considered as the third cause of death. Endocrine cancers are rare but mostly curable. Thyroid cancer, the most common endocrine tumors, includes about one percent of malignant cancer. In this study, we examined the 15-year national tr...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172312/ https://www.ncbi.nlm.nih.gov/pubmed/37164997 http://dx.doi.org/10.1038/s41598-023-34155-2 |
_version_ | 1785039596355059712 |
---|---|
author | Balajam, Narges Zargar Mousavian, Amir-Hossein Sheidaei, Ali Gohari, Kimiya Tavangar, Seyed Mohammad Ghanbari-Motlagh, Ali Ostovar, Afshin Shafiee, Gita Heshmat, Ramin |
author_facet | Balajam, Narges Zargar Mousavian, Amir-Hossein Sheidaei, Ali Gohari, Kimiya Tavangar, Seyed Mohammad Ghanbari-Motlagh, Ali Ostovar, Afshin Shafiee, Gita Heshmat, Ramin |
author_sort | Balajam, Narges Zargar |
collection | PubMed |
description | Cancer is one of the important health problems in Iran, which is considered as the third cause of death. Endocrine cancers are rare but mostly curable. Thyroid cancer, the most common endocrine tumors, includes about one percent of malignant cancer. In this study, we examined the 15-year national trend of endocrine cancer incidence in Iranian men and women. The data in each province were evaluated based on age, gender, and cancer type according to International Classification of Disease Codes version 10 (ICD-10) from 2005 to 2020 in Iran. All data were obtained from the reports of the Statistics Center of Iran (SCI), 6 phases of the step-by-step approach to monitoring the risk factors of chronic diseases over 18 years old (STEPs), and 3 periods of the CASPIAN study (survey of non-communicable diseases in childhood and adolescence). Statistical analyzes and graph generation were done using R statistical software. Poisson regression with mixed effects was used for data modeling and incidence rate estimation. The incidence of thyroid gland malignancy is higher in women than in men. On the other hand, the incidence of adrenal gland cancer is slightly higher in men than in women. The same pattern is observed for other endocrine neoplasms and related structures. The incidence rate of these types of cancers has generally increased from 2005 to 2020 in Iran. This increase is more in women than in men. In addition, in the middle of the country, there is a strong region in terms of the occurrence of these types of cancers. The incidence rate in these provinces is relatively higher for both sexes and all studied periods. We conducted a study to observe the changing trends for various types of endocrine cancers over 15 years in men and women. Considering the increasing trend of thyroid cancers in Iran, therefore, creating essential policies for the management of these types of cancers for prevention, rapid diagnosis, and, timely treatment is particularly important. |
format | Online Article Text |
id | pubmed-10172312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101723122023-05-12 The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020 Balajam, Narges Zargar Mousavian, Amir-Hossein Sheidaei, Ali Gohari, Kimiya Tavangar, Seyed Mohammad Ghanbari-Motlagh, Ali Ostovar, Afshin Shafiee, Gita Heshmat, Ramin Sci Rep Article Cancer is one of the important health problems in Iran, which is considered as the third cause of death. Endocrine cancers are rare but mostly curable. Thyroid cancer, the most common endocrine tumors, includes about one percent of malignant cancer. In this study, we examined the 15-year national trend of endocrine cancer incidence in Iranian men and women. The data in each province were evaluated based on age, gender, and cancer type according to International Classification of Disease Codes version 10 (ICD-10) from 2005 to 2020 in Iran. All data were obtained from the reports of the Statistics Center of Iran (SCI), 6 phases of the step-by-step approach to monitoring the risk factors of chronic diseases over 18 years old (STEPs), and 3 periods of the CASPIAN study (survey of non-communicable diseases in childhood and adolescence). Statistical analyzes and graph generation were done using R statistical software. Poisson regression with mixed effects was used for data modeling and incidence rate estimation. The incidence of thyroid gland malignancy is higher in women than in men. On the other hand, the incidence of adrenal gland cancer is slightly higher in men than in women. The same pattern is observed for other endocrine neoplasms and related structures. The incidence rate of these types of cancers has generally increased from 2005 to 2020 in Iran. This increase is more in women than in men. In addition, in the middle of the country, there is a strong region in terms of the occurrence of these types of cancers. The incidence rate in these provinces is relatively higher for both sexes and all studied periods. We conducted a study to observe the changing trends for various types of endocrine cancers over 15 years in men and women. Considering the increasing trend of thyroid cancers in Iran, therefore, creating essential policies for the management of these types of cancers for prevention, rapid diagnosis, and, timely treatment is particularly important. Nature Publishing Group UK 2023-05-10 /pmc/articles/PMC10172312/ /pubmed/37164997 http://dx.doi.org/10.1038/s41598-023-34155-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Balajam, Narges Zargar Mousavian, Amir-Hossein Sheidaei, Ali Gohari, Kimiya Tavangar, Seyed Mohammad Ghanbari-Motlagh, Ali Ostovar, Afshin Shafiee, Gita Heshmat, Ramin The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020 |
title | The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020 |
title_full | The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020 |
title_fullStr | The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020 |
title_full_unstemmed | The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020 |
title_short | The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020 |
title_sort | 15-year national trends of endocrine cancers incidence among iranian men and women; 2005–2020 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172312/ https://www.ncbi.nlm.nih.gov/pubmed/37164997 http://dx.doi.org/10.1038/s41598-023-34155-2 |
work_keys_str_mv | AT balajamnargeszargar the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT mousavianamirhossein the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT sheidaeiali the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT goharikimiya the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT tavangarseyedmohammad the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT ghanbarimotlaghali the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT ostovarafshin the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT shafieegita the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT heshmatramin the15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT balajamnargeszargar 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT mousavianamirhossein 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT sheidaeiali 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT goharikimiya 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT tavangarseyedmohammad 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT ghanbarimotlaghali 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT ostovarafshin 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT shafieegita 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 AT heshmatramin 15yearnationaltrendsofendocrinecancersincidenceamongiranianmenandwomen20052020 |